rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

argenx SE - American Depositary Shares

ARGX · Nasdaq

Health CareBiotechnologyJust started moving

ARGX stood above a rising 150-day average in 34 of the last 52 weekly readings, including each of the last 1 week. It is 0.1% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
1 in a row
Industry in uptrend
18% -14 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
3
Institutions holding
475 (+28)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 34 of 52 weeks.

21 Apr – 20 Oct
18%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

3 disclosed lines: House 1, Senate 1, executive 1; 3 people.

WhoDidAmountTraded
Alan Armstrong Senate: U.S. Senate eFDSenatorbought$1k–$15k30 Mar 2026filed 21 Jul 2026
Sean P. Duffy Executive branch: Office of Government EthicsDepartment of Transportationsold$1k–$15k11 Feb 2025filed 14 May 2025
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k10 Jul 2023filed 13 Aug 2023

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders475+28 on the quarter
New · exited81 · 54
Reported value$23.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCadded · filed 13 Aug 20265,231,452$4.9B+240,418+4.8%
Jupiter Topco LLCnew · filed 14 Aug 20262,474,015$2.3B+2,474,015
Capital World Investorsreduced · filed 12 Aug 20262,199,770$2.0B-56,446−2.5%
Artisan Partners Limited Partnershipadded · filed 13 Aug 20261,508,778$1.4B+40,796+2.8%
Avoro Capital Advisors LLCunchanged · filed 14 Aug 20261,000,000$927.8M00.0%
WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 2026930,548$863.3M-90,909−8.9%
BlackRock, Inc.reduced · filed 7 Aug 2026777,237$721.1M-31,100−3.8%
RTW INVESTMENTS, LPunchanged · filed 14 Aug 2026709,446$658.2M00.0%
MORGAN STANLEYadded · filed 13 Aug 2026643,123$596.7M+82,412+14.7%
Invesco Ltd.reduced · filed 14 Aug 2026443,990$411.9M-150,707−25.3%
31 Mar 2023 – 30 Jun 2026
242355467Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Alan Armstrong SenateSenator · last 30 Mar 20261 · 0
Sean P. Duffy Executive branchDepartment of Transportation · last 11 Feb 20250 · 1
Daniel S. Goldman HouseNY10 · last 10 Jul 20230 · 1

Same industry

MRNA ModernaLeading+167%
ENTX Entera BioLeading+52%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 31 Dec 20251.8%

Analyst forecasts

No analyst forecasts yet.